kabutan

BrightPath Biotherapeutics, The Current Fiscal Year's Net Income to Widen

Thu May 14, 2026 3:32 pm JST Earnings

4594 BrightPath Biotherapeutics Co., Ltd. 【J-GAAP】

Earnings Report

BrightPath Biotherapeutics Co., Ltd. <4594> [TSE Growth] announced its financial results after the market closed on May 14th (15:32). The net loss (non-consolidated) for the fiscal year ended March 2026 expanded to a loss of 1.30 billion yen (compared to a loss of 1.15 billion yen in the previous period). For the fiscal year ending March 2027, the net loss is expected to be loss of 1.94 billion yen. This will mark the thirteenth consecutive term of losses.

In the most recent three-month period, from January to March (4Q), the net loss expanded to loss of 0.34 billion yen (compared to a loss of 0.33 billion yen in the same period last year).

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 0 -1,155 -1,158 -1,168 -18.2 0 May 10, 2024 J-GAAP
Mar, 2025 1 -1,160 -1,147 -1,151 -14.1 0 May 9, 2025 J-GAAP
Mar, 2026 0 -1,295 -1,293 -1,304 -11.7 0 May 14, 2026 J-GAAP
YoY － -11.6% -12.7% -13.3% +17.1%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Guidance 0 -1,315 -1,308 -1,311 -9.7 0 Mar 13, 2026 J-GAAP
Mar, 2026 Results 0 -1,295 -1,293 -1,304 -11.7 0 May 14, 2026 J-GAAP
Revision Rate － +1.5% +1.1% +0.5% -20.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 0 -464 -460 -462 -4.5 0 Nov 14, 2025 J-GAAP
Apr - Sep, 2026 Guidance ー ー ー ー － 0 May 14, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 1 -1,160 -1,147 -1,151 -14.1 0 May 9, 2025 J-GAAP
Mar, 2026 0 -1,295 -1,293 -1,304 -11.7 0 May 14, 2026 J-GAAP
Mar, 2027 Guidance 0 -1,965 -1,947 -1,949 -14.0 0 May 14, 2026 J-GAAP
YoY － -51.7% -50.6% -49.5% -19.9%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 1 -345 -335 -336 -4.1 -34,500.0 May 9, 2025 J-GAAP
Apr - Jun, 2025 0 -245 -240 -241 -2.6 -Inf Aug 8, 2025 J-GAAP
Jul - Sep, 2025 0 -219 -220 -221 -2.2 -Inf Nov 14, 2025 J-GAAP
Oct - Dec, 2025 0 -492 -492 -493 -4.7 -Inf Feb 13, 2026 J-GAAP
Jan - Mar, 2026 0 -339 -341 -349 -3.1 -Inf May 14, 2026 J-GAAP
YoY － +1.7% -1.8% -3.9% +24.0%

Related Articles